Form 8-K - Current report:
SEC Accession No. 0001144204-19-035118
Filing Date
2019-07-19
Accepted
2019-07-19 09:14:01
Documents
1
Period of Report
2019-07-19
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv525447_8k.htm 8-K 17155
  Complete submission text file 0001144204-19-035118.txt   18495
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37939 | Film No.: 19962404
SIC: 2834 Pharmaceutical Preparations